NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Contact the NSABP

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR

To report problems, ask
questions or make comments,
please send e-mail to:

NSABP Clinical Trials Overview

Protocol B-23
A Clinical Trial Comparing Short, Intensive AC Tamoxifen with Conventional CMF Tamoxifen in Node-Negative Breast Cancer Patients with ER-Negative Tumors

Specific Aims
The specific aims of NSABP Protocol B-23 are: (1) To determine whether four cycles of AC are superior to six cycles of CMF; and (2) to determine whether tamoxifen added to AC or CMF is more efficacious than AC or CMF alone